APA (7th ed.) Citation

(2025). Results from the regency trial assessing efficacy and safety of obinutuzumab in active lupus nephritis.

Chicago Style (17th ed.) Citation

Results from the Regency Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. 2025.

MLA (8th ed.) Citation

Results from the Regency Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. 2025.

Warning: These citations may not always be 100% accurate.